{"id":4855,"date":"2026-05-18T15:16:28","date_gmt":"2026-05-18T15:16:28","guid":{"rendered":"https:\/\/tradertideinsights.com\/?p=4855"},"modified":"2026-05-18T15:16:28","modified_gmt":"2026-05-18T15:16:28","slug":"unitedhealth-slips-after-berkshire-exits-stake-even-as-analysts-see-rebound-ahead","status":"publish","type":"post","link":"https:\/\/tradertideinsights.com\/?p=4855","title":{"rendered":"UnitedHealth slips after Berkshire exits stake even as analysts see rebound ahead"},"content":{"rendered":"<div><\/div>\n<p>Shares of UnitedHealth Group (UNH) fell over 2% on Monday after Berkshire Hathaway disclosed that it had exited its entire position in the health insurer during the first quarter, ending a brief but closely watched investment.<\/p>\n<p>The healthcare giant\u2019s stock had recently staged a strong rebound, posting its seventh consecutive weekly gain after rising about 4% last week. <\/p>\n<p>Berkshire\u2019s latest regulatory filing, however, revealed that the conglomerate sold its full 5.04 million-share stake in UnitedHealth during the quarter ended March 31.<\/p>\n<p>The holding had only been initiated in the second quarter of 2025, meaning Berkshire held the position for less than a year.<\/p>\n<p>The filing marks one of the first major portfolio disclosures since Greg Abel officially became chief executive while Warren Buffett transitioned to the role of chairman.<\/p>\n<p>Berkshire also exited investments in companies including Visa, Mastercard, Amazon, and Domino&#8217;s Pizza, while building a new stake worth roughly $2.65 billion in Delta Air Lines.<\/p>\n<h2 class=\"wp-block-heading\">Healthcare pressures remain in focus<\/h2>\n<p>The Berkshire exit comes at a time when UnitedHealth continues to face several operational and regulatory challenges despite improving investor sentiment.<\/p>\n<p>The company remains under pressure from a federal moratorium that blocks new Medicare enrollments for home healthcare providers, while also navigating a Department of Justice investigation into its billing practices.<\/p>\n<p>At the same time, UnitedHealth is pursuing aggressive measures to protect margins, including plans to reduce its Medicare Advantage enrollment by around 1.3 million members.<\/p>\n<p>Medicare Advantage, the federally subsidised insurance programme for seniors, accounts for roughly 40% of UnitedHealth\u2019s total revenue and remains central to its long-term growth strategy.<\/p>\n<p>The insurer struggled last year as rising medical costs and changes to government reimbursement models weighed heavily on profitability.<\/p>\n<p>However, investor sentiment improved sharply last month after the company reported stronger-than-expected quarterly results that beat Wall Street estimates on both revenue and earnings.<\/p>\n<p>The earnings report helped ease concerns that medical costs would continue to pressure margins and sent the stock up roughly 7% following the release.<\/p>\n<h2 class=\"wp-block-heading\">Goldman sees recovery taking shape<\/h2>\n<p>Earlier this month, analysts at Goldman Sachs added UnitedHealth to the bank\u2019s US Conviction List Director\u2019s Cut, a closely followed selection of high-confidence investment ideas.<\/p>\n<p>Goldman analyst Scott Fidel argued that UnitedHealth could be approaching a \u201csustained positive profit inflection\u201d as pricing adjustments and cost controls begin improving profitability.<\/p>\n<p>The bank noted that the company\u2019s updated pricing for health coverage is now embedded, while healthcare costs are increasingly aligning with management expectations.<\/p>\n<p>Although Fidel forecasts a 4% decline in Medicare Advantage revenue this year, he expects a sharp recovery in profitability, including a projected 50% increase in Medicare Advantage EBIT driven by pricing resets and cost efficiencies.<\/p>\n<p>Artificial intelligence is also expected to play a growing role in reducing operating costs across UnitedHealth\u2019s healthcare services business, particularly within Optum Health.<\/p>\n<p>UnitedHealth plans to reduce membership in its value-based care Optum Health division by roughly 10% this year as part of broader restructuring efforts.<\/p>\n<p>Goldman forecasts annual earnings-per-share growth averaging more than 15% through 2028.<\/p>\n<p>\u201cBottom line, UNH represents a high conviction opportunity to own a best-in-class managed care franchise at the turning point of its earnings cycle,\u201d the Goldman report said.<\/p>\n<p>The bank added that \u201ca durable, multi-year EPS recovery is emerging that is not yet fully appreciated by the market.\u201d<\/p>\n<h2 class=\"wp-block-heading\">Retail traders remain optimistic<\/h2>\n<p>Retail investors appeared largely unfazed by Berkshire\u2019s decision to exit the stock.<\/p>\n<p>Discussion around UnitedHealth surged on social media platform Stocktwits over the past week, with sentiment improving from bearish to neutral territory amid a more than 200% increase in message volume.<\/p>\n<p>Some retail traders argued Berkshire may have exited before the strongest phase of the company\u2019s recovery materialises as profitability stabilises and healthcare demand remains resilient.<\/p>\n<\/p>\n<p>The post <a href=\"https:\/\/invezz.com\/news\/2026\/05\/18\/can-unitedhealth-group-rebound-after-berkshire-hathaways-exit\/\">UnitedHealth slips after Berkshire exits stake even as analysts see rebound ahead<\/a> appeared first on <a href=\"https:\/\/invezz.com\">Invezz<\/a><\/p>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Shares of UnitedHealth Group (UNH) fell over 2% on Monday after Berkshire Hathaway disclosed that it had exited its entire position in the health insurer during the first quarter, ending a brief but closely watched investment.The healthcare giant\u2019s stock had recently staged a strong rebound, posting its seventh consecutive weekly gain after rising about 4%&hellip;<\/p>\n","protected":false},"author":1,"featured_media":4856,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-4855","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-stock"],"_links":{"self":[{"href":"https:\/\/tradertideinsights.com\/index.php?rest_route=\/wp\/v2\/posts\/4855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradertideinsights.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradertideinsights.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradertideinsights.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/tradertideinsights.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4855"}],"version-history":[{"count":0,"href":"https:\/\/tradertideinsights.com\/index.php?rest_route=\/wp\/v2\/posts\/4855\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradertideinsights.com\/index.php?rest_route=\/wp\/v2\/media\/4856"}],"wp:attachment":[{"href":"https:\/\/tradertideinsights.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4855"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradertideinsights.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4855"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradertideinsights.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}